Uploaded via media manager.

Texas, including Austin, is leading the way in COVID-19 research

Recently, the Texas Tribune and KEYE-News, reported that Texas has emerged as a leading site for COVID-19 research, both in the search for a vaccine and for treatments for active cases.

Currently, the state is the site of 130 clinical trials investigating possible vaccines and treatments for the coronavirus, because Texas is home to massive research universities, hundreds of hospitals and unfortunately, a relatively high rate of coronavirus transmission. That’s the most trials of any state other than California and New York, according to the National Institutes of Health.

Austin Regional Clinic vaccine trial

Austin is among the other major Texas cities involved in this research; ARC Clinical Research has been running a COVID-19 vaccine clinical trial since early August. Leaders of vaccine clinical trials say they’ve seen unprecedented numbers of people asking to sign up. “It’s a commonality of really almost all research participants is that they’re doing it for purposes of trying to be helpful, helpful for people in the future even if they think this may not be helpful for themselves,” said Dr. Gretchen Crook, the principal investigator of clinical research at Austin Regional Clinic at ARC Wilson Parke, which is running a double-blind clinical trial with the Pfizer/BioNTech vaccine candidate.

As of mid-September, the clinic had enrolled about 150 participants in its clinical trial and aimed to sign up about 100 more.

“Almost everybody that comes in has this view that this is a really unique opportunity to make a difference in the world, something that they have felt helpless for the last several months watching this catastrophe unfold,” Dr. Crook said.

Learn more about current ARC Clinical Research trials.

Tags: ARC Clinical Research, COVID-19, ARC COVID-19 Care

More on this Topic

ARC Clinical Research contributes to COVID-19 Vaccine Trial

ARC Clinical Research is excited to announce its participation in a prominent COVID-19 vaccine clinical trial that will begin in early August 2020.  ARC will recruit 250 ARC patients from across Central Texas to enroll in this late phase clinical trial. If you are interested in enrolling, please request to participate at ARCclinicalresearch.com or call 512-225-5931.

3 things you should know to stay safe during the pandemic

The development of an effective vaccine has changed the way we are fighting back against COVID. Have questions about the vaccine? Keep reading for tips from ARC doctors.

ARC COVID-19 Vaccination Questions Answered

ARC staff is fielding your questions and aims to make it easy to find out when you can get your vaccine. With a current limited supply of 7,000 doses and over 50,000 ARC patients in Group 1A and 1B, it will take time to vaccinate everyone who is currently prioritized. Here is how we are doing it. Read more.

COVID Vaccine Update: Austin Regional Clinic Vaccinates First Responders; Launches Website for Vaccine Requests

December 30, 2020 — Austin Regional Clinic began vaccinating community first responders yesterday afternoon. Fire trucks from Austin Fire Department lined up at ARC headquarters full of firefighters ready to be vaccinated. ARC expects to vaccinate other regional fire departments and area police departments as well as other first responder groups over the next several weeks. They are also continuing to vaccinate and book appointments with healthcare workers. 

First shipment of Moderna COVID-19 vaccinations arrive at ARC Wednesday, December 23

ARC has received its first shipment of the Moderna COVID-19 vaccine. Based on CDC, state and local health department instructions, we have begun to vaccinate doctors and staff. We are inviting community healthcare workers, first responders, long-term-care staff and school nurses to request a vaccination at ARCshotrequest.com